학술논문
'학술논문'
에서 검색결과 878건 | 목록
1~20
Report
Immune Tolerance Network (ITN); Blood and Marrow Transplant Clinical Trials Network; PPD Development, LP; Rho Federal Systems Division, Inc.
A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology. 2017 Feb 28;88(9):842-852. doi: 10.1212/WNL.0000000000003660. Epub 2017 Feb 1.
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous hematopoieticcell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.
Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE. Autologous HematopoieticCell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant . 2019 May;25(5):845-854. doi: 10.1016/j.bbmt.2019.02.014. Epub 2019 Feb 19.
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology. 2017 Feb 28;88(9):842-852. doi: 10.1212/WNL.0000000000003660. Epub 2017 Feb 1.
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous hematopoietic
Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE. Autologous Hematopoietic
Academic Journal
Massoud, Radwan; Naim, Hassan; Klyuchnikov, Evgeny; Janson, Dietlinde; Wolschke, Christine; Ayuk, Francis; Kröger, Nicolaus
Report
Glucose Control In Hematopoetic Stem Cell Transplant
Academic Journal
Kidney International Reports, Vol 10, Iss 2, Pp S89-S90 (2025)
Academic Journal
Kara M; Yeditepe University Faculty of Medicine, Department of Pediatric Infectious Diseases, İstanbul, Türkiye.; Sütçü M; İstinye University Faculty of Medicine, Department of Pediatric Infectious Diseases, İstanbul, Türkiye.; Adaklı Aksoy B; Altınbaş University Faculty of Medicine, Department of Pediatric Hematology-Oncology and Transplantation Unit, İstanbul, Türkiye.; Zengin Ersoy G; Altınbaş University Faculty of Medicine, Department of Pediatric Hematology-Oncology and Transplantation Unit, İstanbul, Türkiye.; Başoğlu Öner Ö; Altınbaş University Faculty of Medicine, Department of Pediatric Hematology-Oncology and Transplantation Unit, İstanbul, Türkiye.; Yaman A; İstinye University Faculty of Medicine, Department of Pediatric Intensive Care, İstanbul, Türkiye.; Özbek A; Altınbaş University Faculty of Medicine, Department of Microbiology, İstanbul, Türkiye.; Bozkurt C; İstinye University Faculty of Medicine, Department of Pediatric Hematology-Oncology and Transplantation Unit, İstanbul, Türkiye.; Fışgın T; Altınbaş University Faculty of Medicine, Department of Pediatric Hematology-Oncology and Transplantation Unit, İstanbul, Türkiye.
Publisher: Galenos Yayinevi Country of Publication: Turkey NLM ID: 9606065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1308-5263 (Electronic) Linking ISSN: 13007777 NLM ISO Abbreviation: Turk J Haematol Subsets: MEDLINE
Report
Bill and Melinda Gates Foundation; Department of Health and Social Care (DHSC), UK; Biomedical Advanced Research and Development Authority; Wellcome Trust; German Federal Ministry of Education and Research
A Phase 1b/2a, Randomized, Double-blind Study to Investigate Safety, Tolerability, PK, PD, and Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem -Cell Transplantation Receiving Fluoroquinolone Prophylaxis and Harboring Fluoroquinolone-Resistant Escherichia Coli Pre-Transplant
Academic Journal
Clinical Infectious Diseases, 2000 Dec 01. 31(6), 1516-1518.
Academic Journal
American Journal of Kidney Diseases. 83(4):S14-S15
Academic Journal
Natacha Rodrigues; Carolina Branco; Claúdia Costa; Filipe Marques; Marta Neves; Pedro Vasconcelos; Carlos Martins; José António Lopes
Renal Failure, Vol 45, Iss 1 (2023)
Report
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Academic Journal
Caroline G. Bergner; Lisa Schäfer; Vladan Vucinic; Birthe Schetschorke; Julia Lier; Cordula Scherlach; Michael Rullmann; Osama Sabri; Joseph Classen; Uwe Platzbecker; Jörn-Sven Kühl; Henryk Barthel; Wolfgang Köhler; Georg-Nikolaus Franke
Frontiers in Neurology, Vol 14 (2023)
Academic Journal
Wilken, Reason; Fung, Maxwell A; Shi, Vivian Y; Cheng, Michelle Y; Patel, Forum; Sultani, Hawa; Maverakis, Emanual
Dermatology Online Journal. 22(1)
Academic Journal
Reddivalla, Naresh; Robinson, Amie L.; Reid, Kimberly J.; Radhi, Mohamed A.; Dalal, Jignesh; Opfer, Erin K.; Chan, Sherwin S.
Bone Marrow Transplantation. March, 2020, Vol. 55 Issue 3, p523, 8 p.
Report
Effects of a Multidirectional Walking Program on Physical Function and Quality of Life in Hematopoetic Stem Cell Transplant Patients
Report
Tocilizumab (an Anti-human IL-6 Receptor Monoclonal Antibody) as a First Line Therapy for Patients With Glucocorticoid-refractory Acute Graft vs. Host Disease (aGVHD) After Allogeneic Hematopoetic Stem Cell Transplant (HSCT), a Phase II Study.
Report
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients: A Historically-Controlled, Multi-Center Phase 3 Study to Determine Safety & Efficacy
Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC. Multi-institutional use of defibrotide in 88 patients afterstem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood. 2002 Dec 15;100(13):4337-43. doi: 10.1182/blood-2002-04-1216. Epub 2002 Aug 1.
Richardson, Soiffer, Antin, Voss, Jin, Kurtzberget al. Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings. [abstract]. Blood. 2004;104 (11).
Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D'Agostino RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016 Mar 31;127(13):1656-65. doi: 10.1182/blood-2015-10-676924. Epub 2016 Jan 29.
Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC. Multi-institutional use of defibrotide in 88 patients after
Richardson, Soiffer, Antin, Voss, Jin, Kurtzberget al. Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings. [abstract]. Blood. 2004;104 (11).
Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D'Agostino RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016 Mar 31;127(13):1656-65. doi: 10.1182/blood-2015-10-676924. Epub 2016 Jan 29.
Academic Journal
Alsoubani, Majd, MD, MS; Chow, Jennifer, MD, MS
Infectious Disease Clinics of North America. 39(2):309-329
Report
Randomized Double-Blind, Comparison of Standard Dose Trivalent Inactivated Influenza Vaccine Versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Stem Cell Hematopoetic Transplant Recipients
검색 결과 제한하기
제한된 항목
[검색어] Hematopoetic stem cell transplant
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어